纳米载体
医学
疾病
药物输送
药品
靶向给药
痴呆
纳米技术的应用
神经科学
神经保护
纳米技术
风险分析(工程)
药理学
评论文章
药物开发
老龄化社会
疾病治疗
生物信息学
作者
Anushka Sharma,Awaneet Kaur,Javed Khan,Himani Pandey
出处
期刊:Central nervous system agents in medicinal chemistry
[Bentham Science Publishers]
日期:2026-07-06
卷期号:26
标识
DOI:10.2174/0118715249455878260609100548
摘要
Alzheimer's Disease (AD) is a prevalent neurodegenerative disorder characterized by progressive cognitive and behavioral impairment and represents a major cause of dementia worldwide. It primarily affects the elderly population. The disease is marked by progressive neuronal damage, leading to impairments in cognition, behavior, emotions, and communication. Although currently available therapies provide symptomatic relief, they fail to alter disease progression, necessitating the development of more effective therapeutic strategies. Phytoconstituents have gained considerable attention due to their neuroprotective properties and multitargeted mechanisms of action against pathways implicated in AD. However, their clinical application is limited by poor Blood-Brain Barrier (BBB) permeability, low bioavailability, and inadequate solubility. Nanotechnology offers a promising approach for brain-targeted drug delivery by enhancing the therapeutic efficacy of phytoconstituents through advanced nanocarrier systems. This review explores the synergistic potential of phytoconstituents and nanocarriers for the management of AD, aiming to improve therapeutic outcomes and overcome existing limitations. It further highlights the integration of medicinal plant-based compounds with nanotechnology as a novel strategy for AD treatment. The combination of nanocarriers and phytoconstituents may facilitate enhanced BBB penetration and improved neuroprotection. Notably, nanomedicine- based approaches, including phytoconstituent-loaded nanoparticles and liposomes, demonstrate significant potential to overcome delivery barriers and enable efficient drug transport to the brain.
科研通智能强力驱动
Strongly Powered by AbleSci AI